WuXi PharmaTech (Cayman) Inc. Operating Income
WuXi PharmaTech (Cayman) Inc. reported Operating Income of $103.73 million for the 12-month period ending 2014-12-31, per its 20-F filed 2015-04-15.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2015-04-15
| Period end | Operating Income (Loss) 12 month |
|---|---|
| 2014-12-31 | $103.73M 20-F · filed 2015-04-15 |
| 2013-12-31 | $105.24M 20-F · filed 2015-04-15 |
| 2012-12-31 | $89.42M 20-F · filed 2015-04-15 |
| 2011-12-31 | $83.81M 20-F · filed 2014-04-15 |
| 2010-12-31 | $71.50M 20-F · filed 2013-04-17 |
| 2009-12-31 | $52.13M 20-F · filed 2012-04-20 |
| 2008-12-31 | -$20.93M 20-F · filed 2011-04-27 |